University of Cambridge’s DIOS-CoVax2 COVID-19 candidate set for autumn human trials

On Wednesday, in a statement, the University of Cambridge said, it aims to start clinical trials of its COVID-19 candidate in autumn. The development comes in the wake following funding to the tune of 1.9 million pounds from the British government. The approach adopted by the scientists behind the vaccine uses genetic sequences of all…

Cyber attack on Asian ports could cost $110 billion: Lloyd’s of London

A report prepared by University of Cambridge Centre for Risk Studies, on behalf of the Cyber Risk Management (CyRiM) project, in partnership with Lloyd’s, a cyber insurer. On Wednesday, a report backed by Lloyd’s of London stated, a cyber attack on Asian ports could cost a whopping $110 billion equivalent to half of the total…

Cyber security startup Darktrace raises $50 million in latest funding round

The Series E funding round was led by European private equity firm Vitruvian Partners LLP. So far the company has raised $229 million. Darktrace, a cyber-security firm stated, it has raised $50 million in its latest funding round that was led by Vitruvian Partners LLP, an European private equity firm, and saw the startup being…